AHR and cardiac hypertrophy: These findings further corroborate the hypothesis that myocardial hypertrophy is triggered by the activation of IDO1, which subsequently influences AhR-mediated myocardial hypertrophy, and also provide a theoretical basis for the development of IDO1- and KYN-related intervention drugs (92).